Associations of a novel IL4RA polymorphism, Ala57Thr, in Greenlander Inuit

• Main Authors: Khoo, S., Zhang, G., Backer, V., Porsbjerg, C., Nepperchristensen, S., Creegan, R., Baynam, G., Deklerk, N., Rossi, G., Hagel, I., Di Prisco, M.C., Lynch, N., Britton, J., Hill, I., Musk, A.W., Goldblatt, J., Le Souëf, P.N., the Greenlandic Population Study Group, .
• Format: Article in Journal/Newspaper
• Language: English
• Published: Elsevier 2006
• Subjects: Greenland; greenlander*; inuit
• Online Access: https://researchrepository.murdoch.edu.au/id/eprint/46611/

Background A novel IL4RA polymorphism, Ala57Thr, was identified in Greenlander Inuit. Objective We sought to determine whether the novel Thr57 allele is population specific and to assess the associations of Ala57Thr and Ile50Val with atopy in 2 Inuit populations. Methods Ala57Thr and Ile50Val were genotyped in 651 Inuit living in Denmark, 1295 Inuit living in Greenland, and 1329 individuals from 7 populations from widely differing global locations. In Inuit the polymorphisms were evaluated for associations with atopy, rhinitis, asthma, and pulmonary function. Results Thr57 was in linkage disequilibrium with Ile50 (D′ = 1, r2 = 0.13) and was common (33%) in the Inuit but rare (<0.6%) in all other populations. In Inuit living in Denmark, the Thr57 allele (in a dose-dependent manner) and the Ile50/Thr57 haplotype were associated with lower risk of atopy (Plinear = .003 and P = .034, respectively), with similar trends observed for atopic rhinitis and atopic asthma. In Inuit living in Greenland, Thr57 was not associated with atopy or atopic diseases, but Ile50 was weakly associated with lower risk of atopy. Conclusion The novel IL4RA Ala57Thr was common in and population specific to Greenlander Inuit, with Thr57 associated with a lower risk of atopy in those living in Denmark. Hence a full investigation of genotype-phenotype relationships in a given population can only be achieved if each gene is screened for novel polymorphisms in that population. Clinical implications Clinical risk attributable to variations in a gene in an ethnic group requires that all variations of the gene are known for that group.